SpringerLink
Log in

Core needle biopsy and embolization of fat-poor renal tumors in children with tuberous sclerosis complex

  • Research Letter
  • Published:
World Journal of Pediatrics Aims and scope Submit manuscript

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Subscribe and save

Springer+ Basic
EUR 32.99 /Month
  • Get 10 units per month
  • Download Article/Chapter or Ebook
  • 1 Unit = 1 Article or 1 Chapter
  • Cancel anytime
Subscribe now

Buy Now

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Fig. 1
Fig. 2

Data availablility statement

Data is available from the corresponding author on request.

References

  1. Yang P, Cornejo KM, Sadow PM, Cheng L, Wang M, **ao Y, et al. Renal cell carcinoma in tuberous sclerosis complex. Am J Surg Pathol. 2014;38:895–909.

    Article  PubMed  PubMed Central  Google Scholar 

  2. Cajaiba MM, Dyer LM, Geller JI, Jennings LJ, George D, Kirschmann D, et al. The classification of pediatric and young adult renal cell carcinomas registered on the children’s oncology group (COG) protocol AREN03B2 after focused genetic testing. Cancer. 2018;124:3381–9.

    Article  CAS  PubMed  Google Scholar 

  3. Kennedy JM, Wang X, Plouffe KR, Dhanasekaran SM, Hafez K, Palapattu GS, et al. Clinical and morphologic review of 60 hereditary renal tumors from 30 hereditary renal cell carcinoma syndrome patients: lessons from a contemporary single institution series. Med Oncol. 2019;36:74.

    Article  PubMed  Google Scholar 

  4. Amin S, Lux A, Calder N, Laugharne M, Osborne J, O’Callaghan F. Causes of mortality in individuals with tuberous sclerosis complex. Dev Med Child Neurol. 2017;59:612–7.

    Article  PubMed  Google Scholar 

  5. Shepherd CW, Gomez MR, Lie JT, Crowson CS. Causes of death in patients with tuberous sclerosis. Mayo Clin Proc. 1991;66:792–6.

    Article  CAS  PubMed  Google Scholar 

  6. Williams JM, Racadio JM, Johnson ND, Donnelly LF, Bissler JJ. Embolization of renal angiomyolipomata in patients with tuberous sclerosis complex. Am J Kidney Dis. 2006;47:95–102.

    Article  PubMed  Google Scholar 

  7. Kothary N, Soulen MC, Clark TW, Wein AJ, Shlansky-Goldberg RD, Crino PB, et al. Renal angiomyolipoma: long-term results after arterial embolization. J Vasc Interv Radiol. 2005;16:45–50.

    Article  PubMed  Google Scholar 

  8. Halpenny D, Snow A, McNeill G, Torreggiani WC. The radiological diagnosis and treatment of renal angiomyolipoma-current status. Clin Radiol. 2010;65:99–108.

    Article  CAS  PubMed  Google Scholar 

  9. Flum AS, Hamoui N, Said MA, Yang XJ, Casalino DD, McGuire BB, et al. Update on the diagnosis and management of renal angiomyolipoma. J Urol. 2016;195:834–46.

    Article  PubMed  Google Scholar 

  10. Bissler JJ, Kingswood JC, Radzikowska E, Zonnenberg BA, Belousova E, Frost MD, et al. Everolimus long-term use in patients with tuberous sclerosis complex: Four-year update of the EXIST-2 study. PLoS ONE. 2017;12:e0180939.

    Article  PubMed  PubMed Central  Google Scholar 

  11. Rabenou RA, Charles HW. Differentiation of Sporadic Versus Tuberous Sclerosis Complex-Associated Angiomyolipoma. AJR Am J Roentgenol. 2015;205:292–301.

    Article  PubMed  Google Scholar 

  12. Bissler JJ, Racadio J, Donnelly LF, Johnson ND. Reduction of postembolization syndrome after ablation of renal angiomyolipoma. Am J Kidney Dis. 2002;39:966–71.

    Article  PubMed  Google Scholar 

  13. Zöllner JP, Franz DN, Hertzberg C, Nabbout R, Rosenow F, Sauter M, et al. A systematic review on the burden of illness in individuals with tuberous sclerosis complex (TSC). Orphanet J Rare Dis. 2020;15:23.

    Article  PubMed  PubMed Central  Google Scholar 

  14. Lee IS, Nguyen S, Shanberg AM. Needle tract seeding after percutaneous biopsy of Wilms tumor. J Urol. 1995;153:1074–6.

    Article  CAS  PubMed  Google Scholar 

  15. Andersen MF, Norus TP. Tumor seeding with renal cell carcinoma after renal biopsy. Urol Case Rep. 2016;9:43–4.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  16. Volpe A, Mattar K, Finelli A, Kachura JR, Evans AJ, Geddie WR, et al. Contemporary results of percutaneous biopsy of 100 small renal masses: a single center experience. J Urol. 2008;180:2333–7.

    Article  PubMed  Google Scholar 

  17. Hocquelet A, Cornelis F, Le Bras Y, Meyer M, Tricaud E, Lasserre AS, et al. Long-term results of preventive embolization of renal angiomyolipomas: evaluation of predictive factors of volume decrease. Eur Radiol. 2014;24:1785–93.

    Article  CAS  PubMed  Google Scholar 

  18. Hongyo H, Higashihara H, Osuga K, Kashiwagi E, Kosai S, Nagai K, et al. Efficacy of prophylactic selective arterial embolization for renal angiomyolipomas: identifying predictors of 50% volume reduction. CVIR Endovasc. 2020;3:84.

    Article  PubMed  PubMed Central  Google Scholar 

  19. Han YM, Kim JK, Roh BS, Song HY, Lee JM, Lee YH, et al. Renal angiomyolipoma: selective arterial embolization–effectiveness and changes in angiomyogenic components in long-term follow-up. Radiology. 1997;204:65–70.

    Article  CAS  PubMed  Google Scholar 

  20. Planche O, Correas JM, Mader B, Joly D, Mejean A, Helenon O. Prophylactic embolization of renal angiomyolipomas: evaluation of therapeutic response using CT 3D volume calculation and density histograms. J Vasc Interv Radiol. 2011;22:1388–95.

    Article  PubMed  Google Scholar 

  21. Franz DN, Budde K, Kingswood JC, Belousova E, Sparagana S, de Vries PJ, et al. Effect of everolimus on skin lesions in patients treated for subependymal giant cell astrocytoma and renal angiomyolipoma: final 4-year results from the randomized EXIST-1 and EXIST-2 studies. J Eur Acad Dermatol Venereol. 2018;32:1796–803.

    Article  CAS  PubMed  Google Scholar 

  22. Chung NKX, Metherall P, McCormick JA, Simms RJ, Ong ACM. Individualized everolimus treatment for tuberous sclerosis-related angiomyolipoma promotes treatment adherence and response. Clin Kid J. 2022;15:1160–8.

    Article  Google Scholar 

  23. Bissler JJ, Nonomura N, Budde K, Zonnenberg BA, Fischereder M, Voi M, et al. Angiomyolipoma rebound tumor growth after discontinuation of everolimus in patients with tuberous sclerosis complex or sporadic lymphangioleiomyomatosis. PLoS ONE. 2018;13:e0201005.

    Article  PubMed  PubMed Central  Google Scholar 

Download references

Funding

No financial or non-financial benefits have been received or will be received from any party related directly or indirectly to the subject of this article.

Author information

Authors and Affiliations

  1. Department of Medical Imaging, Perth Children’s Hospital, 15 Hospital Avenue, Nedlands, 6009, Australia

    Derek J. Roebuck & Craig Gibson

  2. Division of Paediatrics, Medical School, University of Western Australia, Crawley, 6009, Australia

    Derek J. Roebuck

  3. Department of Radiology, Great Ormond Street Hospital for Children, London, WC1N 3JH, UK

    Samantha Chip**ton

  4. PathWest Laboratory Medicine WA, Murdoch, 6150, Australia

    Bligh D. Berry

Authors
  1. Derek J. Roebuck
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Samantha Chip**ton
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. Bligh D. Berry
    View author publications

    You can also search for this author in PubMed Google Scholar

  4. Craig Gibson
    View author publications

    You can also search for this author in PubMed Google Scholar

Contributions

Credit author statement. DR: writing—original draft, visualization, investigation; SC: investigation, writing—review and editing; BB: investigation, writing—review and editing; CG: investigation, writing—review and editing.

Corresponding author

Correspondence to Derek J. Roebuck.

Ethics declarations

Ethical approval

The ethics committee of Great Ormond Street Hospital specifically exempts retrospective evaluations of patient management from approval. Consent was obtained from the parents of the Perth Children's Hospital patients for publication of their data and images.

Conflict of interest

None of the authors have a conflict of interest.

Additional information

Publisher's Note

Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Roebuck, D.J., Chip**ton, S., Berry, B.D. et al. Core needle biopsy and embolization of fat-poor renal tumors in children with tuberous sclerosis complex. World J Pediatr 19, 614–618 (2023). https://doi.org/10.1007/s12519-023-00692-z

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s12519-023-00692-z

Search

Navigation